These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15769575)

  • 1. Overdose of aripiprazole, a new type of antipsychotic.
    Carstairs SD; Williams SR
    J Emerg Med; 2005 Apr; 28(3):311-313. PubMed ID: 15769575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year experience with aripiprazole exposures.
    LoVecchio F; Watts D; Winchell J
    Am J Emerg Med; 2005 Jul; 23(4):585-6. PubMed ID: 16032649
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign clinical picture after ingestion of 780 milligrams of aripiprazole and 1050 milligrams of amitriptyline.
    Prakash R; Munda S; Pattojoshi A; Choudhary PP
    Indian J Med Sci; 2009 Feb; 63(2):77-80. PubMed ID: 19359772
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical experience: a case series of pediatric aripiprazole exposures.
    Lofton AL; Klein-Schwartz W
    Clin Toxicol (Phila); 2005; 43(3):151-3. PubMed ID: 15902787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole (abilify) overdose in a child.
    Seifert SA; Schwartz MD; Thomas JD
    Clin Toxicol (Phila); 2005; 43(3):193-5. PubMed ID: 15902794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily dose of 105 mg aripiprazole because of delusional origin: a case report.
    Wichowicz H; Wilkowska A; Landowski J
    Psychiatr Danub; 2012 Dec; 24(4):400-1. PubMed ID: 23132192
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe extrapyramidal symptoms in a 3-year-old boy after accidental ingestion of the new antipsychotic drug aripiprazole.
    Schonberger RB; Douglas L; Baum CR
    Pediatrics; 2004 Dec; 114(6):1743. PubMed ID: 15574656
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged toxicity in a 2-year-old after accidental ingestion of aripiprazole.
    Melhem S; Katz K; Jameson A; Shellenbarger D; Akhtar J
    Pediatr Emerg Care; 2009 Feb; 25(2):105-6. PubMed ID: 19225379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2009 Apr; 607(1-3):35-40. PubMed ID: 19217900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic.
    Buckley PF
    Drugs Today (Barc); 2003 Feb; 39(2):145-51. PubMed ID: 12698209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.
    Tan HH; Hoppe J; Heard K
    Am J Emerg Med; 2009 Jun; 27(5):607-16. PubMed ID: 19497468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine partial agonists: a new class of antipsychotic.
    Lieberman JA
    CNS Drugs; 2004; 18(4):251-67. PubMed ID: 15015905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
    Keck PE; McElroy SL
    Expert Opin Investig Drugs; 2003 Apr; 12(4):655-62. PubMed ID: 12665420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical impact of aripiprazole in patients suffering from schizophrenia].
    Levoyer D; Drapier D; Fadier-Salicé G; Millet B
    Encephale; 2007; 33(3 Pt 1):332-8. PubMed ID: 17675931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2011 Oct; 668(3):355-65. PubMed ID: 21816144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of new antipsychotic medications: occupancy is not just antagonism.
    Grunder G; Carlsson A; Wong DF
    Arch Gen Psychiatry; 2003 Oct; 60(10):974-7. PubMed ID: 14557141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.